Disc Medicine Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | – | – | – | – | – | |
| – | -90.1% | +178.1% | +12.4% | +56.0% | +80.1% | |
| – | -48.4% | +312.0% | +164.7% | +204.1% | +104.2% | |
| – | +1,492.2% | – | – | – | – | |
| – | +281.6% | +65.2% | -239.0% | – | +9.1% | |
| – | +209.1% | +122.1% | -41.1% | +467.4% | +84.8% | |
| – | +209.1% | +122.1% | -41.1% | +328,362.9% | +34.9% | |
| – | – | – | – | – | -100.0% | |
| – | +162.6% | +65.7% | +60.7% | -8.8% | +116.8% | |
| – | +4,008.6% | +71.0% | +55.6% | -201.3% | – | |
| – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.